US Stock MarketDetailed Quotes
PRQR ProQR Therapeutics
- 1.8699
- -0.0601-3.11%
Trading Aug 1 11:40 ET
152.70MMarket Cap-5237P/E (TTM)
2.0000High1.8200Low23.51KVolume1.8800Open1.9300Pre Close44.91KTurnover0.04%Turnover RatioLossP/E (Static)81.66MShares3.290052wk High4.06P/B108.08MFloat Cap1.110052wk Low--Dividend TTM57.80MShs Float27.6000Historical High--Div YieldTTM9.33%Amplitude0.5300Historical Low1.9100Avg Price1Lot Size
ProQR Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 579.39%4.45M | 81.25%6.51M | 356.11%3.28M | 68.30%1.37M | 29.57%1.21M | -42.04%655K | 169.21%3.59M | 227.27%720K | -6.65%814K | 282.72%930K |
| Operating revenue | 579.39%4.45M | 81.25%6.51M | 356.11%3.28M | 68.30%1.37M | 29.57%1.21M | -42.04%655K | 169.21%3.59M | 227.27%720K | -6.65%814K | 282.72%930K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 24.70%12.53M | -39.92%41.3M | -5.29%12.48M | -57.70%8.76M | -40.37%10.05M | -44.73%10.04M | 17.44%68.75M | -21.21%13.18M | 31.79%20.71M | 21.68%16.86M |
| Selling and administrative expenses | -14.26%3.45M | -12.95%16.24M | 59.83%4.75M | -38.14%3.32M | -23.41%4.15M | -17.97%4.03M | 7.39%18.65M | -44.09%2.97M | 16.73%5.36M | 31.30%5.41M |
| -General and administrative expense | -14.26%3.45M | -12.95%16.24M | 59.83%4.75M | -38.14%3.32M | -23.41%4.15M | -17.97%4.03M | 7.39%18.65M | -44.09%2.97M | 16.73%5.36M | 31.30%5.41M |
| Research and development costs | 53.18%9.28M | -50.56%25.15M | -27.72%7.73M | -64.53%5.45M | -48.39%5.91M | -54.66%6.06M | 20.48%50.87M | -14.11%10.7M | 38.01%15.35M | 17.61%11.45M |
| Other operating expenses | -400.00%-210K | 89.54%-80K | --0 | ---- | ---- | 58.42%-42K | 26.65%-765K | ---491K | ---- | ---- |
| Operating profit | 14.00%-8.08M | 46.61%-34.79M | 26.17%-9.2M | 62.85%-7.39M | 44.45%-8.85M | 44.91%-9.39M | -13.89%-65.16M | 24.53%-12.46M | -34.05%-19.9M | -17.02%-15.93M |
| Net non-operating interest income expense | 189.71%488K | 127.68%1.39M | 118.47%1.1M | -39.40%363K | -59.59%470K | 33.82%-544K | -47.68%-5.02M | -555.78%-5.96M | 125.19%599K | 147.20%1.16M |
| Non-operating interest income | ---- | 2,346.23%2.59M | ---- | ---- | ---- | ---- | 2,020.00%106K | ---- | ---- | ---- |
| Non-operating interest expense | ---- | -76.54%1.2M | ---- | ---- | ---- | ---- | 50.57%5.13M | ---- | ---- | ---- |
| Total other finance cost | -189.71%-488K | ---- | ---- | 39.40%-363K | 59.59%-470K | -33.82%544K | ---- | ---- | -125.19%-599K | -147.20%-1.16M |
| Other net income (expense) | -106.31%-68K | -7.99%5.59M | -48.84%2.62M | 139.80%1.57M | -72.41%360K | -71.30%1.08M | 8,533.33%6.07M | 6,222.22%5.12M | -761.49%-3.94M | 245.24%1.31M |
| Gain on sale of security | ---- | -105.36%-255K | ---- | ---- | ---- | ---- | 214.82%4.76M | ---- | ---- | ---- |
| Earnings from equity interest | ---- | --0 | --0 | --0 | --0 | ---- | 96.31%-8K | --0 | --0 | --0 |
| Special income (charges) | --0 | 451.73%4.89M | 97.77%2.93M | 136.08%1.45M | -91.17%101K | --408K | -370.43%-1.39M | --1.48M | ---4.02M | --1.14M |
| -Less:Other special charges | ---- | -234.24%-1.87M | --0 | -133.79%-1.36M | 91.17%-101K | ---408K | --1.39M | ---1.48M | --4.02M | ---1.14M |
| -Gain on sale of business | ---- | --92K | --0 | --92K | ---- | ---- | --0 | --0 | --0 | ---- |
| -Gain on sale of property,plant,equipment | ---- | --2.93M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non- operating income (expenses) | -110.15%-68K | -64.87%953K | 94.99%-56K | 49.37%118K | 60.87%259K | -82.20%670K | 244.31%2.71M | 16.88%-1.12M | 124.31%79K | -57.41%161K |
| Income before tax | 13.55%-7.66M | 56.62%-27.81M | 58.81%-5.48M | 76.50%-5.46M | 40.44%-8.02M | 37.24%-8.86M | -5.65%-64.11M | 23.29%-13.3M | -54.55%-23.24M | 14.25%-13.46M |
| Income tax | 3K | -181.25%-78K | 5K | -159.42%-41K | -310.00%-42K | 0 | -17.95%96K | 0 | 97.14%69K | -62.26%20K |
| Net income | 13.52%-7.66M | 56.80%-27.74M | 58.77%-5.48M | 76.74%-5.42M | 40.84%-7.98M | 37.27%-8.86M | -5.60%-64.2M | 23.38%-13.3M | -54.65%-23.3M | 14.41%-13.48M |
| Net income continuous Operations | 13.52%-7.66M | 56.80%-27.74M | 58.77%-5.48M | 76.74%-5.42M | 40.84%-7.98M | 37.27%-8.86M | -5.60%-64.2M | 23.38%-13.3M | -54.65%-23.3M | 14.41%-13.48M |
| Minority interest income | 0 | 74.55%384K | 0 | 1,971.43%290K | -92.63%16K | 1,075.00%78K | 472.88%220K | 84.21%-3K | 163.64%14K | 3,200.00%217K |
| Net income attributable to the parent company | 14.27%-7.66M | 56.35%-28.12M | 58.77%-5.48M | 75.51%-5.71M | 41.66%-7.99M | 36.69%-8.93M | -6.07%-64.42M | 23.32%-13.3M | -54.97%-23.32M | 12.99%-13.7M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 14.27%-7.66M | 56.35%-28.12M | 58.77%-5.48M | 75.51%-5.71M | 41.66%-7.99M | 36.69%-8.93M | -6.07%-64.42M | 23.32%-13.3M | -54.97%-23.32M | 12.99%-13.7M |
| Basic earnings per share | 18.18%-0.09 | 61.11%-0.35 | 61.11%-0.07 | 78.79%-0.07 | 47.37%-0.1 | 45.00%-0.11 | 5.26%-0.9 | 30.77%-0.18 | -50.00%-0.33 | 20.83%-0.19 |
| Diluted earnings per share | 18.18%-0.09 | 61.11%-0.35 | 61.11%-0.07 | 78.79%-0.07 | 47.37%-0.1 | 45.00%-0.11 | 5.26%-0.9 | 30.77%-0.18 | -50.00%-0.33 | 20.83%-0.19 |
| Dividend per share | ||||||||||
| Currency Unit | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR | EUR |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg